Author:
Espinosa-Garavito Alberto C.,Quiroz Elkin Navarro,Galán-Freyle Nataly J.,Aroca-Martinez Gustavo,Hernández-Rivera Samuel P.,Villa-Medina Joe,Méndez-López Maximiliano,Gomez-Escorcia Lorena,Acosta-Hoyos Antonio,Pacheco-Lugo Lisandro,Espitia-Almeida Fabián,Pacheco-Londoño Leonardo C.
Abstract
AbstractArterial hypertension (AH) is a multifactorial and asymptomatic disease that affects vital organs such as the kidneys and heart. Considering its prevalence and the associated severe health repercussions, hypertension has become a disease of great relevance for public health across the globe. Conventionally, the classification of an individual as hypertensive or non-hypertensive is conducted through ambulatory blood pressure monitoring over a 24-h period. Although this method provides a reliable diagnosis, it has notable limitations, such as additional costs, intolerance experienced by some patients, and interferences derived from physical activities. Moreover, some patients with significant renal impairment may not present proteinuria. Accordingly, alternative methodologies are applied for the classification of individuals as hypertensive or non-hypertensive, such as the detection of metabolites in urine samples through liquid chromatography or mass spectrometry. However, the high cost of these techniques limits their applicability for clinical use. Consequently, an alternative methodology was developed for the detection of molecular patterns in urine collected from hypertension patients. This study generated a direct discrimination model for hypertensive and non-hypertensive individuals through the amplification of Raman signals in urine samples based on gold nanoparticles and supported by chemometric techniques such as partial least squares-discriminant analysis (PLS-DA). Specifically, 162 patient urine samples were used to create a PLS-DA model. These samples included 87 urine samples from patients diagnosed with hypertension and 75 samples from non-hypertensive volunteers. In the AH group, 35 patients were diagnosed with kidney damage and were further classified into a subgroup termed (RAH). The PLS-DA model with 4 latent variables (LV) was used to classify the hypertensive patients with external validation prediction (P) sensitivity of 86.4%, P specificity of 77.8%, and P accuracy of 82.5%. This study demonstrates the ability of surface-enhanced Raman spectroscopy to differentiate between hypertensive and non-hypertensive patients through urine samples, representing a significant advance in the detection and management of AH. Additionally, the same model was then used to discriminate only patients diagnosed with renal damage and controls with a P sensitivity of 100%, P specificity of 77.8%, and P accuracy of 82.5%.
Funder
Ministry of Science, Technology And Innovation of Colombia
Ministry of Science, Technology and Innovation of Colombia
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Williams, B. et al. 2018 ESC/ESH Guidelines for themanagement of arterial hypertension. Eur. Heart J. 39, 3021–3104. https://doi.org/10.1093/eurheartj/ehy339 (2018).
2. Setters, B. & Holmes, H. M. Hypertension in the older adult. Prim. Care 44, 529 (2017).
3. O’Shea, P. M., Griffin, T. P. & Fitzgibbon, M. Hypertension: The role of biochemistry in the diagnosis and management. Clin. Chim. Acta 465, 131–143 (2017).
4. La Lopera-Medina, M. M. enfermedad renal crónica en Colombia: Necesidades en salud y respuesta del Sistema General de Seguridad Social en Salud. Rev. Geren. Polit. Salud 15, 212–233 (2016).
5. Crowley, S. D. & Coffman, T. M. The inextricable role of the kidney in hypertension. J. Clin. Investig. https://doi.org/10.1172/JCI72274 (2014).